FIELD: medicine.
SUBSTANCE: group of inventions relates to a rocuronium preparation. Rocuronium preparation for reducing and/or relieving vascular pain caused by the use of rocuronium contains rocuronium and a buffer solution and has a titratable acidity of 80 mEq or less and a pH from 2.5 to 4.5, provided that titratable acidity means the amount of sodium hydroxide in mEq consumed during the titration of 1 l of solution to a pH of 7.4. Method of producing a rocuronium preparation is also disclosed, which includes a step of adjusting the titratable acidity of the rocuronium preparation, and a method of reducing and/or relieving vascular pain caused by rocuronium, including adjusting the titratable acidity of the rocuronium preparation.
EFFECT: group of inventions provides a rocuronium preparation with improved suppression of vascular pain.
5 cl, 1 dwg, 1 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
ROCURONIUM PREPARATION WITH IMPROVED STABILITY | 2014 |
|
RU2705996C2 |
ROCURONIUM PREPARATION WITH IMPROVED STABILITY | 2019 |
|
RU2724900C1 |
PHARMACEUTICAL COMPOSITIONS FOR USE IN TREATMENT OF PAIN | 2020 |
|
RU2812902C2 |
METHOD OF PREPARING THE PRESERVED MEDICINAL AGENT CONTAINING HUMAN PROTEIN FOR INJECTION OR INFUSION ADMINISTRATION | 1992 |
|
RU2091068C1 |
STABILIZED LIQUID COMPOSITIONS OF NEUROMUSCULAR BLOCKERS | 2013 |
|
RU2695226C2 |
COMPOSITIONS AND METHODS FOR PAIN RELIEF | 2018 |
|
RU2777368C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2604690C2 |
LIPOSOMAL COMPOSITION FOR APPLICATION IN PERITONEAL DIALYSIS | 2013 |
|
RU2609860C2 |
Pharmaceutical composition based on tramadol for ophthalmic use | 2016 |
|
RU2744570C2 |
METHODS AND COMPOSITIONS WHICH ALLOW MODULATION OF IMMUNE RESPONSES RELATED TO ADMINISTRATION OF BIOPHARMACEUTICAL DRUG | 2014 |
|
RU2662558C2 |
Authors
Dates
2019-02-21—Published
2014-06-23—Filed